Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8

Explore clinical trials studying Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 trial results

Recruiting

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

NCT04930653

Conditions: Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

City of Hope Medical Center Duarte, California, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

View Trial Details

Completed

Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides

NCT03695471

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +21 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8

Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 trial results

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides

Related conditions